Vanguard Investments Australia
AVNS

Vanguard Investments Australia’s Avanos Medical AVNS Stock Holding History

Vanguard Investments Australia’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
12,245
+2,273
+23% +$53.2K ﹤0.01% 1921
2026
Q1 		$140K Buy
+9,972
New +$134K ﹤0.01% 2187

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Investments Australia's AVNS Position: Q2 2026 in Review

Vanguard Investments Australia increased its Avanos Medical (AVNS) stake by 23% in Q2 2026, buying an estimated $53.2K and bringing the position to 12,245 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

Vanguard Investments Australia first reported a position in AVNS in Q1 2026 and has held it in 2 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Vanguard Investments Australia held 12,245 shares of Avanos Medical worth $305K as of Q2 2026.
  • Vanguard Investments Australia bought 2,273 Avanos Medical shares in Q2 2026, an estimated $53.2K.
  • Avanos Medical made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1921 holding.
  • Vanguard Investments Australia first reported a position in Avanos Medical in Q1 2026 and has held it in 2 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.